UK consumers reduced their purchases of food and alcohol during the festive season, with industry experts attributing this trend to the impact of weight loss injections. Grocery sales reached £19.6 billion in the four weeks leading up to December 27, marking a 2.5% increase from the previous year, according to NielsenIQ. However, sales volume showed a slight decrease of 0.2%.
Analysts point to the growing popularity of GLP-1 injections, which replicate a key hormone signaling fullness in the body, as a contributing factor to the decline in food and alcohol sales. The National Health Service (NHS) prescribes weight loss injections like Mounjaro and Wegovy, along with Ozempic for diabetes, with an estimated 1.6 million UK adults having used these injections in the past year.
Retail experts have observed a noticeable shift in consumer behavior, with individuals opting for smaller meal options and nutrient-dense products. Major retailers such as Co-op, Marks & Spencer, and Iceland have introduced new product lines catering to this evolving trend of conscious consumption.
Industry leaders like Greggs, Tesco, and Sainsbury’s are closely monitoring consumer preferences in light of the rise of weight loss medications. Greggs’ CEO highlighted the demand for smaller portions and healthier choices among customers, while Tesco and Sainsbury’s CEOs emphasized the importance of adapting to changing shopper habits.
The impact of weight loss jabs on consumer behavior is evident, prompting retailers to adjust their offerings to meet the evolving needs of health-conscious customers.